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Abstract 
Skeletal muscle fibre types are determined by the activity of motor neurons, hormones, 
stretch and probably cell lineage. The electrical activity of the motor neurons might, through an 
unknown pathway, influence the expression of a unique set of muscle specific genes in the 
different fibre types. 
 MRF4 is a member of a family of myogenic basic helix-loop-helix transcription factors 
(bHLH) that is important for the development of muscle fibres. These transcription factors are 
also suggested to be important in adult muscle, where they might be a possible link between 
electrical activity and expression of muscle specific genes. The myogenic bHLH transcription 
factors MyoD and myogenin has been shown to possible be involved in the regulation of fibre 
type specificity. This role is also proposed for MRF4, based on the high amount of MRF4 mRNA 
that is expressed in all adult skeletal muscle types and that it seems to be preferentially expressed 
in slow fibre types. 
In this thesis I wanted to further examine if MRF4 might possible contribute in the 
regulation of fibre type specificity in normal adult skeletal muscles.  
MRF4 was overexpressed in the fast glycolytic calf muscle; extensor digitorum longus 
(EDL). Plasmids containing the MRF4 gene and a reporter gene were transfected into the muscle 
by electroporation. After 14 days there was no change in the cross-sectional area or SDH activity 
in MRF4-transfected fibres compared to the control (sham)-transfected fibres. There were a 
significant higher number of 2b fibres in both MRF4- and sham-transfected fibres compared to 
normal, non-transfected fibres. This higher amount of 2b fibres is speculated to be caused by a 
possible selective transfection of the largest fibres as an effect of electroporation properties, or an 
effect of the lacZ itself or both. 
 These results indicate that MRF4 induces no change in MyHC isoforms, cross-sectional 
area and oxidative metabolism in normal adult skeletal muscle and this does not support the 
hypothesis that MRF4 may have a role in regulating fibre type specific patterns of muscle gene 
expression in adult skeletal muscle.
  
Table of Contents 
1. INTRODUCTION.................................................................................................................................................... 1 
1.1. FIBRE TYPES ........................................................................................................................................................ 1 
1.2. FIBRE TYPE TRANSITIONS .................................................................................................................................... 2 
1.3. MECHANISMS INVOLVED IN FIBRE TYPE TRANSITIONS......................................................................................... 4 
1.4. MYOGENIC DETERMINATION FACTORS................................................................................................................ 6 
1.5. MYOGENESIS....................................................................................................................................................... 6 
1.6. MDF’S IN ADULT MUSCLES ................................................................................................................................. 8 
1.7. MYOGENIC BHLH FACTORS AND FIBRE TYPE SPECIFICITY .................................................................................. 9 
1.8. MRF4- A ROLE IN REGULATION OF FIBRE PHENOTYPE IN ADULT SKELETAL MUSCLE? ...................................... 10 
1.9. AIM OF THE STUDY ............................................................................................................................................ 11 
2. MATERIAL AND METHODS............................................................................................................................. 12 
2.1. OVERWIEV ........................................................................................................................................................ 12 
2.2. ANIMAL EXPERIMENTS ...................................................................................................................................... 13 
2.3. PLASMIDS ......................................................................................................................................................... 13 
2.4. TRANSFECTION OF PLASMIDS ............................................................................................................................ 15 
2.4.1. Transfection in Tissue Culture ............................................................................................................. 15 
2.4.2. Electroporation .................................................................................................................................... 15 
2.5. HISTOLOGY ....................................................................................................................................................... 16 
2.5.1. Freezing of EDL................................................................................................................................... 16 
2.5.2. Preparation of cryosections ................................................................................................................. 16 
2.5.3.  β-gal staining ...................................................................................................................................... 17 
2.5.4. SDH staining ........................................................................................................................................ 17 
2.5.5. Staining for Myosine heavy chain isoforms.......................................................................................... 17 
2.6. IMAGING ........................................................................................................................................................... 18 
2.6.1. Fluorescence imaging .......................................................................................................................... 18 
2.6.2. Bright Field Imaging............................................................................................................................ 18 
2.7. QUANTITATIVE HISTOCHEMISTRY..................................................................................................................... 19 
2.7.1. SDH activity ......................................................................................................................................... 19 
2.8. CALCULATION OF CROSS SECTIONAL AREA ....................................................................................................... 19 
2.9. STATISTICAL METHODS .................................................................................................................................... 19 
3. RESULTS ............................................................................................................................................................... 20 
3.1. OVERVIEW ........................................................................................................................................................ 20 
3.2. FIBRE TYPES ..................................................................................................................................................... 21 
3.3. CROSS-SECTIONAL AREA .................................................................................................................................. 24 
3.4. SDH ACTIVITY .................................................................................................................................................. 26 
4. DISCUSSION ......................................................................................................................................................... 28 
4.1. DOES MRF4 HAVE AN EFFECT ON MYHC EXPRESSION? ................................................................................... 28 
4.2. HAS MRF4 AN EFFECT ON THE CROSS-SECTIONAL AREA?................................................................................. 30 
4.3. HAS MRF4 AN EFFECT ON THE OXIDATIVE METABOLISM? ................................................................................ 30 
4.4. DOES MRF4 HAVE NO ROLE IN REGULATING FIBRE TYPE SPECIFIC PATTERNS OF GENE EXPRESSION?............... 31 
4.5. OTHER POSSIBLE FUNCTIONS OF MRF4?........................................................................................................... 32 
4.6. FUTURE PERSPECTIVES...................................................................................................................................... 33 
4.7. CONCLUSIONS ................................................................................................................................................... 34 
5. APPENDIX A ......................................................................................................................................................... 35 
5.1. EQUETHESIN (CATALOGNUMBER 702821, ULLEVÅL FARMASY)........................................................................ 35 
5.2. PAP- MRF4 DNA SOLUTION (100µL)............................................................................................................... 35 
5.3. PAP-MRF4 AND PAP-LACZ DNA SOLUTION (100µL) ...................................................................................... 35 
5.4. STAINING FOR β-GAL ACTIVITY......................................................................................................................... 36 
  
 
5.5. STAINING FOR SDH ACTIVITY ........................................................................................................................... 37 
5.6. STAINING OF MYHC ......................................................................................................................................... 38 
6. APPENDIX B ......................................................................................................................................................... 39 
6.1. ABBREVIATIONS................................................................................................................................................ 39 
7. REFERENCES....................................................................................................................................................... 40
Chapter 1                                                                                                                        Introduction 
                                                                                                                                                     1 
1. Introduction 
Skeletal muscles are composed of structurally, functionally and metabolically distinct 
fibre types. The different fibre types have the ability to change their size, composition of fibre 
types and enzymatic properties to accommodate altered functional demands. These alterations 
can occur because of altered electrical activity due to exercise, mechanical loading and unloading 
and hormones and aging, which all defines the muscle plasticity. This plasticity requires changes 
in the gene expression of muscle specific genes. There have been several studies on the pathways 
that link electrical activity to gene expression, and in this thesis I propose MRF4 to be a possible 
link between electrical activity and gene expression. 
 
1.1. Fibre types 
The fibre type diversity and transition abilities in skeletal muscles depend on the 
expression of the proteins that are involved in the excitation-contraction-relaxation cycle and 
their isoforms. The most common way to distinguish between the different fibre types is to look 
at the different myosine heavy chain isoforms (MyHCs) they express, and the different metabolic 
enzyme activity levels. Mammalian skeletal muscles express 11 MyHC isoforms and four of 
these are expressed in adult rodent skeletal muscle.  
In the 19th century the fibre types was categorized as “red” with slow muscle contraction 
and “white” with fast muscle contraction. These have later been classified as type I, type IIa and 
type IIb fibres based on their ATPase activity and pH liability (Brooke & Kaiser, 1970). The 
ATPase activity varies by how fast the ATP is hydrolysed during the cross-bridge cycling in the 
exitation-contraction coupling. This variation in ATP activity has been shown to correlate with 
variation in contraction speed and MyHC isoform expression in the different fibre types (Reiser 
et al., 1985)  
With the use of methods like electrophoretic analysis of MyHC isoforms (Reiser et al., 
1985), mATPase histochemistry (Brooke & Kaiser, 1970) and immunohistochemistry using 
antibodies against the MyHC isoforms (Schiaffino et al., 1989), the different MyHCs in skeletal 
muscle are now classified into four main groups: MyHCIβ, ΜyΗCΙΙa, MyHCIIx and MyHCIIb. 
  The MyHCIβ represents the slow type I fibre type, with slow contraction speed and high 
oxidative capacity. The MyHCIIa, MyHCIIx and MyHCIIb represent the three fibre types; IIa, 
IIx and IIb in the fast type II population. Within the fast fibre population, the type IIa fibres have 
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fast contraction speed and have an oxidative-glycolytic metabolisme. The type IIb fibres have the 
fastest contraction speed and a glycolytic metabolism. The type IIx fibres are intermediates of 
these   (Bottinelli et al., 1991; Bottinelli et al., 1994a; Bottinelli et al., 1994b) see table 1.1.  
MyHCIIb has been shown not to be expressed in human or other large mammalian muscle 
(Smerdu et al., 1994). 
 
Fibre Type Myosin Heavy Chain Contraction Speed Metabolic activity Endurance 
I MHCIb Oxidative Good 
IIa MHCIIa Medium 
IIx MHCIIx 
Oxidative-
glycolytic Poor 
IIb MHCIIb 
Slow 
 
 
Fast Glycolytic Very Poor 
 
Table 1.1 Overview of the MHC contends and physical properties of the different fibre types. 
 
 
 
1.2. Fibre type transitions 
Muscle fibres have the capacity to alter their physical and functional properties to meet 
functional demands. These alterations can occur because of changed expression of the different 
proteins involved in the excitation-contraction-relaxation cycle due to altered nerve activity, 
mechanical loading and unloading, hormones and aging.  
The nerve and electrical activity has an important influence on muscle contraction and 
fibre type composition (Gundersen, 1998). An alteration in the electrical activity induces a 
change in fibre type properties. In the absence of electrical activity by denervation, slow muscles 
become faster and fast muscles become slower (Huey & Bodine, 1998). Lomo et al, (1974) 
denervated the slow twitch soleus muscle and stimulated it with an electrical pattern normal for a 
fast twitch muscle, and saw that the slow soleus muscle attained several properties characteristic 
of a fast muscle. The opposite is true for stimulation of the fast EDL muscle with an electrical 
pattern normal for a slow twitch muscle; it will become more like a slow twitch muscle (Eken & 
Gundersen, 1988). 
 The conversion of a slow twitch muscle to a fast twitch muscle and a fast twitch muscle 
to a slow twitch muscle also seem to induce a change in myosin heavy chain composition and 
thus a change in fibre type composition. 
 Rat EDL consist of on average 45% type IIB, 29% type IIX, 23% type IIA and 3% type I 
fibres (Windisch et al., 1998). Ausoni et al, (1990) showed that EDL muscles stimulated with a 
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slow pattern, showed a predominans of IIa-IIx type fibres, no fast type IIb-MyHC expression and 
a normal type I-MyHC expression whereas when the soleus muscle, which consist of on average 
85 % type I fibres, 15 % IIa fibres, less than 1 % IIx fibres and no , IIb fibres (Rhana, master 
thesis 2003, Ausoni et al., 1990), was stimulated with a fast pattern, developed a predominans of 
IIa-IIx fibres, small amounts of type I-MyHC and no type IIb-MyHC (Ausoni et al., 1990).  
(Windisch et al., 1998) showed that after stimulating the EDL muscle with a slow pattern 
for 4 months, all fibres reacted with the type 1 antibody, which indicate an almost complete 
transformation. This ability to an almost complete transformation in the EDL is also seen in the 
other direction in the soleus muscle. After 40 days of stimulation with a fast pattern the MyHCI 
isoform is redused to less than 35% and MyHCIIx becomes the prominent MyHC. MyHCIb 
increased to approximately 15% (Hamalainen & Pette, 1996).   
Studies have also shown the existents of hybrid fibres. Hybrid fibres consist of two or 
sometimes more, MyHC isoforms (Pette & Staron, 1990; Schiaffino & Reggiani, 1996; 
Stephenson, 2001). The hybrid fibres are classified according to their MyHC isoform 
combinations: MyHCI+MyHCIIa (type I/IIa), MyHCIIa+MyHCIIx (type IIa/IIx), and 
MyHCIIx+MyHCIIb (type IIx/IIb). Hybrid fibres exist in normal fibres but are mostly common 
in fibres undergoing molecular and functional transitions: 
 
Fast to slow conversion: IIb        IIb/IIx           IIx     IIx/IIa    IIa           IIa/I           I 
 
Slow to fast conversion: I  I/IIa          IIa           IIa/IIx           IIx           IIx/IIb          IIb         
 
During exercise training, muscles experiences an increased neuromuscular activity similar 
to what is seen when stimulating a muscle with chronic low-frequency stimulation, but to a lesser 
extent than with direct stimulation of the muscle. Exercise increases oxidative enzyme 
metabolism (Baldwin et al., 1972; Holloszy & Booth, 1976) and in some cases induces fast-to-
slow MyHC transitions, but this transition is limited to shifts in the slow direction in the fast fibre 
type population (Andersen and Henriksson, 1977). Extreme exercise might induce transitions 
from the fast fibre population to type I fibres (Demirel et al., 1999). 
 Strech overload (Pattullo et al., 1992), reduced levels of thyroid hormones (Fitts et al., 
1980) and aging (Larsson & Ansved, 1995) also induces a fast-to slow conversion in muscle 
phenotype. 
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1.3. Mechanisms involved in fibre type transitions 
Skeletal muscle fibre types are, amongst other factors, determined by the activity of the 
motor neuron that innervates them and the unique set muscle specific genes the different fibre 
types express. These are well known facts, but the pathways that link the motor neuron activity 
with the expression of these muscle specific genes are still unclear. However, recent studies can 
now unravel several suggestions to what these pathways could look like. 
 A well studied pathway that is suggested to control skeletal muscle fibre types is the 
calcineurin dependent transcriptional pathway. Calcineurin can interact with several downstream 
substrates to activate gene transcription, and one of these is the nuclear factor of activated t-cells 
(NFAT) transcription factors. Calsineurin dephosphorylate NFAT so that NFAT can migrate to 
the nucleus and bind to transcriptional regulators.  
Chin et al, (1998) found that the calcineurin dependent pathway influences fibre-type-
specific gene expression in the fast to slow direction in cultured cells. They proposed a model 
where tonic motor nerve activity, characteristic of nerves that innervate slow muscles, sustains a 
Ca2+ level suffient to activate the calcineurine-NFAT pathway. Fast fibres, with infrequent, 
phasic firing of the motor nerve, were of insufficient duration to maintain calcineurin activation. 
They also found that NFAT can bind to the Mef-2 transcription regulator which is important in 
activating the myogenic bHLH factors. The role of the calsineurin-NFAT pathway has also been 
proven to have the same effect in adult skeletal muscle in vivo (McCullagh et al., 2004).  
Calcineurin can also act through factors other than NFAT to promote the slow fibre type 
program. Calcineurin dependent gene regulation in skeletal myocytes is also mediated by Mef-2 
either through NFAT or in the absence of NFAT. Mef-2 can also be stimulated in the absence of 
calcineurin but in the presence of calmodulin-dependent protein kinase activity, but the effect on 
Mef-2 is greatly enhanced in the presence of both calcineurin and CaMK (Wu et al., 2000). 
Another pathway involved in promoting nerve-activity-dependent differentiation of slow 
muscle fibres in vivo is the Ras-MAPK pathway. Activated Ras induces the expression of slow 
MyHC (Murgia et al., 2000). 
Myogenin is a bHLH transcription factor that is mostly expressed in slow fibre types 
(Voytik et al., 1993), and myogenin seems to mediate transcription of oxidative genes and is 
proposed to be linked to slow motor neuron activity via the calcineurin pathway (Ekmark et al., 
2003).  
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PPARδ is a transcription factor that also seems to mediate expression of slow fibre type 
genes. PPARδ is activated by free fatty acids, and slow motor neuron activity due to exercise is 
known to up-regulate this ligand. PPARδ is also known to be activated by PGC-1 which is a co-
factor that physically associates with PPARδ in muscle tissue and can strongly activate PPARδ 
even in the absence of ligands (Wang et al., 2004). 
Slow-to-fast fibre transformation occurs as a consequence of decreased motor neuron 
activity, due to cross-innervation, certain disease states or physical inactivity. MyoD is a bHLH 
factor that is highly expressed in fast fibre types (Voytik et al., 1993) and is proposed to be linked 
to a pathway mediating fast motor neuron activity to fast fibre gene transcription (Ekmark, 
unpublished). Possible signalling pathways and cross-reactions are shown in figure 1.1 
 
    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Overiew of signalling pathways that might link electrical activity to transcription factors and gene 
expression. 
 
 
 
 
Ca2+Calsineurin 
Slow motor neuron activity 
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CaMK MAPK
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                                       Slow or oxidative genes 
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1.4. Myogenic determination factors 
The myogenic determination factors are a group of transcription factors that belongs to a 
family of conserved basic helix-loop-helix transcription factors (bHLH). These myogenic 
determination factors are known to have an important function in the development of somite cells 
into muscle cells, known as the myogenesis. 
 The myogenic bHLH proteins can form heterodimers with the HLH protein E12 which 
binds the consensus DNA E-box CANNTG sequence (figure 1.2). E-box sequences are found in 
both promotor and enhancer areas of muscle specific genes (Olson, 1990; Buonanno et al., 1992; 
Emerson, 1993; Weintraub, 1993). 
 Other studies have shown that members of the myocyte enhancer factor-2 (MEF-2) family 
of MADS-box transcription factors are important in the myogenesis. The MEF-2 binding site has 
been identified in control regions of almost all skeletal muscle genes. These factors cooperate 
with myogenic bHLH factors to activate muscle gene expression. This indicates that activation 
signals from both the MEF-2 and the myogenic bHLH factors are required for initiation of the 
myogenesis (Reviewed by (Black & Olson, 1998) 
 
 
 
 
 
 
 
Figure 1.2 Potential mechanisms for activation of skeletal muscle transcription by MEF2 and myogenic 
bHLH factors (Black & Olson, 1998) 
 
 
 
1.5. Myogenesis 
The myogenesis is the formation of somite progenitor cells into myoblasts, myocytes and 
myotubes.  Further differentiation of the myotubes forms the skeletal muscle fibres. 
 The formation of skeletal muscle fibres are driven by the expression of four myogenic 
determination factors MyoD, Myf- 5, myogenin and MRF4 (Davis et al., 1987; Braun et al., 
1989; Edmondson & Olson, 1989; Rhodes & Konieczny, 1989; Wright et al., 1989; Braun et al., 
1990; Miner & Wold, 1990).  
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The four myogenic factors are expressed at different stages during the myogenesis; Myf-5 
transcripts can be seen at E8 as the segmentation of the somites begins. The myogenin mRNA is 
detectable at E8.5 when myotomal muscle begins to form. The MRF4 mRNA is expressed 
transiently at E9 and only in the myotomes. After E16 the MRF4 mRNA is expressed in all 
skeletal muscles and becomes the dominant transcription factor in adult skeletal muscle. MyoD 
mRNA can be seen at E10.5 and the expression persists throughout the prenatal life (Sassoon et 
al., 1989; Bober et al., 1991; Hinterberger et al., 1991; Ott et al., 1991; Arnold & Braun, 1996).  
 Because the myogenic factors are expressed at different times and at different levels 
during the myogenesis, it indicates that they have different functions throughout the myogenesis. 
To investigate the role of the myogenic factors during myogenesis, several studies on inactivation 
of the myogenic factor genes have been conducted.  
 Mice lacking the functional MyoD gene are viable and fertile, and exhibit no 
morphological or physiological abnormalities. All myogenic mRNA is expressed at normal levels 
except that of Myf-5 which is increased 3.5-fold, suggesting that normal Myf-5 expression is 
inhibited by MyoD, or that Myf-5 compensates for the lack of MyoD (Rudnicki et al., 1992). 
  Mice lacking Myf-5 showed normal development of skeletal muscle but died 
immediately after birth because of major rib abnormalities that impedes breathing (Braun et al., 
1992). 
  To further explore the roles of Myf-5 and MyoD in the myogenesis, mice lacking both 
MyoD and Myf-5 were investigated. These mice were born alive but were immobile and died 
soon after birth. There was no formation of skeletal muscle which suggests that either Myf-5 or 
MyoD is required for the determination of skeletal myoblast, their proliferation or both (Rudnicki 
et al., 1993).  
 Mice lacking the myogenin gene die immediately after birth and show severe reduction of 
all skeletal muscle. This suggests that myogenin plays an important role in the differentiation of 
myoblasts into myotubes. The MRF4 mRNA level is decreased, indicating that myogenin might 
be necessary for normal MRF4 levels (Hasty et al., 1993).  
 Mice lacking the MRF4 gene were viable and showed no abnormalities in the muscle 
formation, but there were defects in the rib development. No other skeletal defects were 
observed. There was an up-regulation of myogenin mRNA that suggests that MRF4 normally 
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represses myogenin expression after birth and might compensate for the absence of MRF4 
(Zhang et al., 1995). 
  These results taken together suggests that Myf-5 and MyoD are primary myogenic 
determination factors that are important for the development of somatic cells into myoblasts, and 
that myogenin and MRF4 are secondary determination factors that are important for the 
differentiation of myoblasts into myocytes and myotubes. 
  The role of MRF4 as a secondary determination factor has been the general conception, 
but a resent study has shown that MRF4 also might be one of the early determination factors. A 
study by Kassar-Duchossoy, (2004) indicates that MRF4 also contributes to the determination of 
skeletal myoblast (figure 1.3) 
 The results also indicate that these myogenic factors are involved in a cross-regulatory 
network in which the activity of one factor regulates its own and other myogenic bHLH gene’s 
expression. 
 
 
Figur 1.3 Myf-5, MyoD and possible MRF4 determine the formation of somatic cells into myogenic cells. 
Myogenin and MRF4 trigger the formation of myoblast into myotubes and myofibres. (Modified figure from 
(Charge & Rudnicki, 2004) 
  
 
 
1.6. MDF’s in adult muscles 
The myogenic factors have proven to play an important role during the myogenesis, but 
they are also continued to be expressed in the adult muscle, suggesting that they might be 
important in modulating gene expression in adult muscles and thereby contribute to the diversity 
of individual muscle phenotypes and muscle plasticity.  
 Myogenin and MyoD are expressed in different amounts in slow and fast muscles. 
Myogenin is expressed in high levels in muscles with a high amount of slow fibre types, and in 
Myf5/MyoD/MRF4 Myogenin/MRF4
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low levels in muscles with high amounts of fast fibre types. MyoD is expressed in high levels in 
muscles with a high amount of fast fibre types and in low levels in muscles with a high amount of 
slow fibres (Hughes et al., 1993; Voytik et al., 1993). 
 MRF4 and Myf-5 is expressed at in both fast and slow muscles; MRF4 is expressed at 
equal high levels in all muscle types, whereas Myf-5 is expressed at equal low levels in all 
muscle types (Hughes et al., 1993; Voytik et al., 1993). 
 
1.7. Myogenic bHLH factors and fibre type specificity 
Based on the different distribution of the myogenic bHLH factors between different 
muscle types, there is reason to believe that these factors contribute to muscle fibre type 
specificity. Hughes et al, (1993) showed that MyoD and myogenin mRNAs accumulate in 
muscles that differ in contractile properties. MyoD accumulates in fast twitch muscles and 
myogenin accumulates in slow twitch muscles. Huges et al, (1993) also found that thyroid 
hormone treatment resulted in activation of both MyoD and fast MyHC gene expression in the 
slow soleus, and that cross-reinnervation of the soleus with a fast nerve results in decreased 
myogenin mRNA expression in regions now induced to express fast MyHC. 
 Hughes et al, (1997) studied the fibre type composition in MyoD null mice. In the 
absence of MyoD, there was a shift from a fast to a slower phenotype in fast muscles. In contrast, 
slow muscle shifts toward a faster phenotype. 
 In a current studie, the MyoD gene has been overexpressed in the slow soleus muscle, and 
immunohistological analysis shows an increase in fibre types that expresses the fast MyHCs, 
which indicates a shift in the slow-to-fast direction (Ekmark,unpublished data) 
  Myogenin also show the ability to change muscle phenotype. Overexpression of 
myogenin in transgenic mice showed a 2-3 fold elevation of oxidative mitochondrial enzymes in 
fast muscles and a reduced level of glycolytic enzymes. This revealed a myogenin induced shift 
in enzyme activity from glycolytic to oxidative metabolisme (Hughes et al., 1999).  
Overexpression of myogenin in pre-existing adult fibres in the fast EDL muscle, showed an 
increase in oxidative enzyme levels and a reduction in the fibre cross-sectional area, without 
changes in the major MyHC fibre type (Ekmark et al., 2003). This indicates a change in the slow 
direction similar to the change in muscle fibres during endurance training.  
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1.8. MRF4- A role in regulation of fibre phenotype in adult skeletal muscle? 
 MRF4 mRNA is expressed in high amounts in both fast and slow muscles (Voytik et al., 
1993), but Walters et al, (2000) found that in a mixed muscle, such as the gastrocnemius muscle, 
there was a higher expression of MRF4 in the deeper parts which consists of mostly type I fibres, 
than in the surface part of the muscle which consists mostly of type II fibres. Based of these 
findings they suggested that MRF4 might exhibit a fibre type specific pattern of expression in 
adult muscles. 
The bHLH myogenic factors have been suggested to be involved in regulation of fibre 
type specific patterns in adult muscles. MyoD has been suggested to have a role in regulation and 
maintaining a fast fibre type pattern and myogenin has been suggested to be involved in the 
regulation of oxidative capacity and fibre size(strength) in  the slow direction (Hughes et al., 
1997; Ekmark et al., 2003).  
Both MRF4 and myogenin expression is regulated by the binding of their subunit to the 
consensus DNA E-box CANNTG sequence. E box sequences are found in both promotor and 
enhancer areas of muscle specific genes (Olson, 1990; Buonanno et al., 1992; Emerson, 1993; 
Weintraub, 1993). MRF4 and myogenin also bind to Mef-2 which is known to activate 
transcription of muscle specific genes (Black & Olson, 1998). Studies with knock out mice 
suggest that myogenin has a compensatory role in the absence of MRF4 and that myogenin is 
necessary for normal levels of MRF4 (Hasty et al., 1993; Zhang et al., 1995). 
 These studies suggest that MRF4 might have a role similar to that of MyoD and 
myogenin in regulating fibre type specific patterns in adult skeletal muscle and then possible in 
the slow direction, like myogenin. 
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1.9. Aim of the study 
Will overexpression of MRF4 in adult skeletal muscle induce changes in fibre type 
composition, oxidative capacity and fibre cross-sectional area? 
 
MRF4 was transfected into muscle fibres in the fast EDL muscle by electroporation, to see if 
MRF4 might induce changes in MyHC isoforms, cross-sectional area and oxidative capacity to a 
pattern normal in slow fibre types.
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2. Material and Methods 
 
2.1. Overwiev 
  The Extensor digitorum longus (EDL) in rat was surgically exposed and transfected with 
plasmids containing either the MRF4 gene and reporter gene lacZ or just the reporter gene as a 
control. The plasmids were transfected by electroporation. After 14 days, the electroporated EDL 
muscles were removed and freezed and cross sections were prepared. Histological analyses, like 
staining for β- gal, SDH and myosin heavy chains (MyCH), were conducted on neighbouring 
sections (figure 2.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Anaesthetising of rat  
        Exposal of EDL 
         Electroporation 
      Reanaesthetising of rat 
 Removal and freezing of EDL 
 Preparation of cross sections 
         Histological analysis 
14 days
Stored at -800C 
 
Stored at -800C
Figure 2.1 Overview of the experimental methods
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2.2. Animal experiments 
The experiments were performed on male wistar rats (200-400g), delivered by the Norwegian 
institute of public health, and kept in animal research facilities at the University of Oslo. The 
animals were kept in cages in rooms with a regulated temperature at 22°C and with air humidity 
at 50-60%. Food and water were given ad libitum. 
 The animals were anesthestetised by interperitoneal injections with Equthisin (5µl/g) 
(appendix A, 5.1) and the effect of the anesthetics were controlled by pinching the metatarsian 
region of the rat leg to check for absents of reflex. If necessary, extra anesthesia was 
administrated. When the animal were under deep anesthesia, hair were first removed by shaving 
the leg with a machine and followed by applying hear removal cream (Veet for sensitive skin, 
Reckitt and Coleman). The rat was laid on a cork plate and the leg was fixed on to a styrofoam 
bloc by pinning it in a locked position between the toes. The extensor digitorium longus (EDL) 
muscle was exposed surgically and DNA was injected and then transfected into the muscle cells 
by electroporation. The wound was surgically closed with sutures. 
 All animal experiments were approved by the Norwegian Animal Research Authority and 
were conducted in accordance to the Norwegian Animal Welfare Act of December 20th, 1974, 
no. 37, chapter VI, sections 20-22, and the Regulation on Animal Experimentation of January 
15th 1996. 
   
2.3. Plasmids 
The rat EDL muscle was injected with a DNA solution containing a mix of the plasmids pAP-
MRF4 (figure 2.2B) and pAP-lacZ in the right muscle. Studies have shown that two plasmids that 
are coinjected will be coexpressed after transfection (Rana et al, 2004). The left EDL muscle was 
injected only with the pAP-lacZ plasmid (figure 2.2A) as a control. 
The pAP-lacZ plasmid (Kisselev et al., 1995) contain the Escherichia Coli β-galactosidase 
coding sequence driven by the Rouse sarcoma virus (RSV) promoter and an origin of replication 
driven by a SV40 promotor. 
 The construction of pAP-MRF4 was made by first cloning the isolated MRF4 PCR 
product in to an Easy vector (promega, protocol.) and further cloned into a pGEFP vector by 
cutting the Easy vector with EcorI. From the pGEFP vector, the MRF4 was cloned in to the pAP 
–vector, made by removing the β-galactosidase coding sequence by cutting it with BamHI and 
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HindIII. The MRF4 was cloned into the pAP-vector after cutting the multiple restriction sites in 
pGEFP with BamHI and HindIII for directional insertion. The pAp-MRF4 plasmid now contains 
a MRF4 coding sequence driven by the RSV promoter and an origin of replication driven by the 
SV40 promotor. 
 
 
 
A                                                                          B 
 
 
 
 
 
 
 
 
 
Figure 2.2 Plasmids. 
A. The plasmid pAP-lacZ gene which expresses the β-galactosidase protein. B. The plasmid pAP-MRF4 contains the 
MRF4 gene which expresses the MRF4 protein 
 
 
 
Experiment groups Plasmids Overexpressed protein 
Normal - - 
Control pAP-lacZ β-galactosidase 
MRF4 pAP-MRF4 MRF4 
 
 
 
 
 
Figur 2.2 Plasmids 
A.The plasmid pAP-lacZ contains the lacZ gene which expresses the β-galactosidase 
protein. B. The plasmid pAP-MRF4 contains the MRF4 gene which expresses the MRF4 
protein. 
Table 2.1 Overview of the experiment groups 
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2.4. Transfection of plasmids 
2.4.1. Transfection in Tissue Culture 
To test for expression of MRF4, human embryonic kidney cells (HEK-239) were transfected with 
pAP MRF4 and pAP-lacZ as a control, using the Lipofectamine2000 kit (Invitrogen). The MRF4 
protein were extracted from these cells and visualized by western blotting (figure 2.3). The 
MRF4 protein was visualized by first applying a specific MRF 4 antibody, kindly donated by 
Andres Buannano, and then by applying a secondary goat anti mouse IgG antibody (Southern 
Biotech).  
 
 
 
 
        
        
        
    
 
 
 
 
 
 
2.4.2. Electroporation 
Transfection of the DNA was performed in vivo as described previously by Mathiesen 
(1999). The Extensor digitorium longus (EDL) muscle was exposed surgically and 100µl DNA 
(appendix A, 5.2 and 5.3) was injected through a Hamilton syringe to the centre of the muscle. 
The muscle was then subjected to an electrical field by a pulse generator (Pulsar 6bp-a/s, Fredrick 
Haer & Co). Two silver electrodes, 1mm thick, placed ca 3mm a part were moved along the 
muscle and five trains of bipolar pulses (200µs long in each direction) with a peak to peak 
     35kD   
 
 
      24kD  
          S             M Figure 2.3 Expression of MRF4 in tissue culture. 
Western blot of protein extracts from human 
embryonic kidney cells transfected with the sham (S) 
plasmid pAP-lacZ or the MRF4 (M) overexpressing 
plasmid pAP-MRF4. 
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voltage of 50V were run across the muscle (figure 2.4). The electrical charge was registered with 
an analogue oscilloscope (03245A, Gould Advance). 
 
 
        
         
              
 
 
 
 
 
 
 
2.5. Histology  
2.5.1. Freezing of EDL 
The EDL muscle was surgically removed 14 days after transfection of the DNA. The 
muscle was lightly stretched between two pins on a double layer of thin wax blocks. The muscle 
was then lowered into a container with liquid isopentane which was cooled down to the freezing 
point at ca -160°C with liquid nitrogen. After frozen in isopentane, the muscle was lowered into 
liquid nitrogen before contained in cooled cryotubes (Nunc Cryoflex TM  Tubling)  and stored at -
80 °C. 
 
2.5.2. Preparation of cryosections     
The muscle was fastened to a holder by applying O.C.T Compound (Tissue Tek) and then 
mounted in the cryotome (HM560M Microme). The muscle tissue was kept at a temperature of -
18°C and the cutting knife was kept at a temperature of  -24°C. 10µm serial sections was made 
and placed on microscope slides and stored at -80°C for further analysis. 
 
 
 
Figur 2.4 Electroporation 
To silver electrodes on each side of  the  EDL 
muscle, which has been injected and baded in 
DNA solution, creates an electrical charge across 
the muscle. 
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2.5.3. β-gal staining 
β-gal is the reporter protein used in this experiment. Staining for β-gal activity will 
identify the transfected fibres. β-gal is determined histochemically (appendix A, 5.4) by adding 
5-brom-4chloride-3indoloyle-β-D-galactoside (x-gal) to the sections. β-gal will hydrolyze to the 
colourless product indoxyle. Indoxyle dimerises and gives blue coloured crystals (figure 2.5). 
The crystals do not solve in water so the colour becomes permanent after mounted in glycerine 
gel. Staining without x-gal as substrate gave no blue fibres. 
 
            Figure 2.5 Staining for β-gal 
               The picture shows a cross section of the EDL muscle 
               stained for β-gal. The fibres transfected with lacZ is here shown       
               in black. 
 
 
 
2.5.4. SDH staining 
SDH is an enzyme localized in the mitochondria which catalyses the oxidation of 
succinate to fumarate in the citric acid cycle. The oxidative capacity of a muscle can be measured 
by the level of SDH activity in the muscle fibres. The determination of the SDH activity was 
performed as described by Bancroft (1975). SDH catalyses the reduction and protonation of 
tetrazolium to formazan, when succinate is used as a substrate. Tetrazolium is colourless and 
non-solvent in water while formazan is a crystalloid and projects a blue-purple colour (appendix 
A, 5.5). The colour stays permanent when mounted in glycerine gel. Staining without succinate 
as substrate gave no staining. 
 
 
2.5.5. Staining for Myosine heavy chain isoforms 
Monoclonal antibodies against MyHC I, MyHCIIa, MyHCIIb and all MyCHII (kindly 
provided by Stefano Schiaffino) were used to determine muscle fibre types. For visualizing the 
specific binding of primary antibodies, secondary antibodies were conjugated to the reporter 
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protein rhodamin and applied to the sections (table 2.2, appendix A 5.6). When rhodamin is 
looked at through green light, it will appear red. The fibres with the specific antibodies can then 
be visualized and identified. Staining without the primary antibodies gave no fluorescence for 
any of the primary antibodies. 
 
MyHC Primary antibody Secondary antibody 
I              BA-DF Anti-Mouse Ig, Rhodamine (1214608, Boeheringer) 
IIa SC-71 Anti-Mouse Ig, Rhodamine (1214608, Boeheringer) 
All II              MY-32 Anti-Mouse Ig, Rhodamine (1214608, Boeheringer) 
IIb              BF-F3     Anti-mouse IgM, Cy-3 (J115-165-020, Jackson              
ImmunoResearch Laboratories) 
 
Table 2.2 Overview of the antibodies used for staining for MyHC isoforms. 
 
 
2.6. Imaging 
2.6.1. Fluorescence imaging 
Pictures of sections marked with antibodies conjugated to rhodamin were taken by a SIT 
video camera (C2400-08, Hamatsu). The camera was connected to a microscope (BX50WI, 
Olympus) with 10x and 20x water immersion objectives (UMPlan FI, Olympus). The filter cube 
XF33 ( Omega Optical) was used to give a green light and select for the red light emitted from 
rhodamin. 
 
 
2.6.2. Bright Field Imaging   
Bright field pictures of sections stained for β-gal and SDH activity were taken by a CCD 
video camera (C2400, Hamatsu). The camera was connected to a microscope (BX50W1, 
Olympus) with 10x and 20x water immersion objectives (UMFPlanF1, Olympus). The images 
were digitalized through an image-processing unit (Argus-20, Hamatsu) before they were 
transferred to a Power Macintosh G3 computer.  
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2.7. Quantitative Histochemistry 
2.7.1. SDH activity 
SDH activity was measured in fibres that overexpressed MRF4, control transfected fibres 
and in normal fibers. SDH activity was determined by measuring the colour intensity in ImageJ 
(NIH). The fibres of interest were manually encircled and the mean pixel grey value was 
measured from a scale from 0 (white) to 253 (black). The scale was standardised for all 
individual sections to be able to compare the individual sections. 
 
2.8.  Calculation of cross sectional area 
As encircling the fibres to measure SDH activity, the mean cross sectional area were also 
measured. The area was measured as number of pixels and was later converted to µm by 
calibrating against a µm scale. 
 
2.9. Statistical Methods 
An unpaired t-test and Anova with a Bonferroni post-test was used for statistic comparison of 
enzyme activity and cross-section area between the experiment groups.The level of significance 
was chosen to 5%. 
 A Fisher’s exact test was used for statistic comparison of number of fibres transfected 
between MRF-, sham- and non-transfected fibres. Fisher’s exact test calculates 2X2 contingency 
tables where the values are numbers of observations, and calculates the probability that each of 
these tables would have been obtained by chance. 
 The statistical calculations were performed in Graphpad  Prism. 
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3. Results 
3.1. Overview 
 Fibre type, cross-sectional area and SDH activity was identified and quantified in EDL 
muscles electroporated with either pAP-lacZ or both pAP-MRF4 and pAP-lacZ. Fibres 
electroporated with pAP-lacZ, which express the β-gal protein, are described as control 
transfected fibres, or sham fibres. Fibres electroporated with both pAP-lacZ and pAP-MRF4 are 
described as MRF4 transfected fibres, and is considered to overexpress MRF4. The transfected 
fibres were identified by staining for β-gal activity, as the fibres positive for β-gal activity 
appears as blue fibres.  A number of non-transfected fibres were randomly picked in the near 
vicinity of the transfected fibres in both MRF4-transfected muscles and sham-transfected 
muscles. These are described as MRF4-normal fibres and sham-normal fibres and acts as an 
additional control within each muscle. Neighbour sections were stained for β-gal activity, SDH 
activity and MyHC isoforms and compared for analysis (figure 3.1). 
      
 
     
 
Figure 3.1 Cross sections of the EDL muscle electroporated with pAP-lacZ and pAP-MRF4. 
The cross sections are stained for β-gal activity, SDH activity, MyHC IIa, MyHC IIb and all MyHC II. β-gal positive 
fibres are shown as black or grey fibres. The difference in the strength of the SDH staining is a measure of the 
difference in SDH activity. Stronger staining means higher SDH activity. The transfected fibres are marked M 
(MRF4). Non-transfected fibres or normal fibres are marked N. Looking at the MyHC staining, one can see that all 
the M and N marked fibres are all type 2b fibres except the M* which in this case is a 2x fibre. Exsamples of 2a, 2x 
and 2b fibres is marked on the pictures. 
β-gal SDH
MyHC 2a MyHC 2b All MyHC II 
*
2a
2x
2b
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3.2. Fibre Types 
 The distribution of fibre types were identified by counting the number of 2a, 2x and 2b 
fibres in MRF4-transfected fibres, MRF4-normal fibres, sham-transfected fibres and sham-
normal fibres (table 3.1). 
 The normal distribution of  fibre types in normal EDL muscles is on average 45% type 
IIB, 29% type IIX, 23% type IIA and 3% type I fibres (Windisch et al., 1998). This coincide with 
the fibre type distribution in the MRF4-normal and sham-normal fibres in this study (table 3.1, 
figure 3.2) (because of only very few observed type I fibres, I have not included these in the 
results).  
 Because the total number of transfected fibres and the number of transfected 2a, 2x and 
2b fibres varies between the individual muscles (table 3.2), the fibre type distribution is analysed 
as percentage of the total number of fibres in each experiment group. 
 There is a significant higher number of 2b fibres in both the MRF4-transfected fibres and 
the sham-transfected fibres (p<0.0001) and significant fewer 2a and 2x fibres (p<0.0001, 
p=0.0030) compared to the normal fibres. The results also show a significant higher number of 
2b of sham-transfected fibres (p=0.0001) and subsequent significant fewer 2a and 2x fibres in 
sham-transfected fibres (p=0.0176, p=0.0066) compared to the MRF4-transfected fibres. There is 
no significant difference in number of 2a, 2x and 2b fibres between MRF4-normal and sham 
normal fibres (table 3.1, figure 3.2)  
 Comparing the number of 2b fibres in the MRF4-transfected muscles with sham 
transfected muscles, it looks as if there has been a transformation of MyHC isoforms in the slow 
direction, but if we compare both the MRF4- and sham transfected fibres with the normal fibres, 
this effect is not seen. The higher amount of 2b fibres in both MRF4- and sham-transfected fibres 
is speculated to be caused by a possible selective transfection of the largest fibres as an effect of 
electroporation properties, or an effect of the lacZ itself or both. 
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Fibre types 2a 2x 2b  
Experiment group n (%) n  (%) n  (%) Total 
MRF4 30  (7,6) * 80  (20,2) * 286  (72,2) * 396 
Sham 13  (3,5) * 48  (12,8) *    314  (83,7) *§ 375 
MRF4-normal 78  (19,6) 117  (29,4) 202  (51,0 397 
Sham-normal 71  (19,2) 118  (32,0) 180  (48,8) 369 
 
Table 3.1 Number and percentage of 2a, 2x, 2b fibres in the different experiment groups. 
*There are a significant higher number of 2b fibres and significant fewer 2a and 2x fibres in MRF4- and sham-
transfected fibres compared to the normal distribution. § There are a significant higher number of 2b fibres in sham-
transfected fibres compared to MRF4-transfected fibres. There is no significant difference in the fibre type 
distribution between the MRF4- and sham-normal fibres. 
 
 
 
 
 
Figure 3.2 Pai charts showing the fibre type distribution in percentage of the total number of fibres in each 
experiment group. 
There are a significant higher number of 2b fibres in both the sham -and MRF4-transfected fibres compared to 
MRF4-normal and sham-normal fibres. There is significant fewer 2a and 2x fibres in the sham -and MRF4-
transfected fibres. There are a significant higher number of 2b fibres in the sham-transfected fibres compared to the 
MRF4-transfected fibres. There is no significant difference in the number of 2a, 2x and 2b fibres between MRF4-
normal fibres and sham-normal fibres. 
MRF4-transfected 
2a 
2x 
2b 
Sham-transfected 
2a
2x
2b
MRF4-normal 
2a 
2x 
2b 
Sham-normal 
2a
2x 
2b
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 Fibre types 2a 2x 2b  
Rat Experiment group n  (%) n   (%) n  (%) Total 
MRF4 1  (4,3) 3  (13,1) 19  (82,6) 23 
Sham 2  (3,7) 7  (13,0) 45  (83,3) 54 
MRF4-normal 6  (26,1) 4  (17,4) 13  (56,6) 23 
 
A 
 
 Sham-normal 12  (22,6) 17  (32,1) 24  (45,3) 53 
MRF4 2  (2,6)  11  (14,5)  63  (82,9) 76 
Sham* NA NA NA  
MRF4-normal 23  (30,3) 20  (26,3) 33  (43,4) 76 
 
B 
Sham-normal* NA NA NA  
MRF4 5  (6,2) 26  (32,1) 50  (61,7) 81 
Sham 9  (9,7) 21  (22,6) 63  (67,7 93 
MRF4-normal 8  (9,9) 25  (30,9) 48  (59,3) 81 
 
C 
Sham-normal 17  (19,1) 32  (35,6) 40  (44,9) 89 
MRF4 13  (11,5) 28  (24,8) 72  (63,7) 113 
Sham 0  (0)  4  (8,0) 46  (92,0) 50 
MRF4-normal 34  (29,8) 40  (35,1) 40  (35,1) 114 
 
D 
Sham-normal 8  (16,0) 16  (32,0) 26  (52,0) 50 
MRF4 9  (8,7) 12  (11,7) 82  (79,6) 103 
Sham 2  (1,1) 16  (9,0) 160  (89,9) 178 
MRF4-normal 7  (6,8) 28  (27,2) 68  (66,0) 103 
 
E 
Sham-normal 34  (19,2) 53  (29,9) 90  (50,8) 177 
 
Table 3.2 Number and percentage of 2a, 2x and 2b fibres within the experiment groups in the different 
individes. 
The total number of transfected fibres and the number of transfected 2a, 2x and 2b fibres varies in the animals and 
the individual muscles. The percentage distribution of the fibre types in each animal show however an overall higher 
number in 2b fibres in sham-transfected fibres compared to MRF4-transfected fibres. 
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3.3. Cross-sectional Area 
 The cross-sectional area was measured in the transfected and normal fibres in all four 
experiment groups. In normal fibres, the 2a fibres have the lowest cross-sectional area while the 
2b fibres have the highest. The 2x fibres have an intermediate cross-sectional area of these (figure 
3.3). 
 Analysis of the average cross-sectional area of all muscles taken together, show a 
significant difference in the cross-sectional area in the 2a, 2x and 2b fibres of the MRF4-
transfected fibres compared to sham-transfected fibres and in the MRF4-normal fibres compared 
to sham-normal fibres, but not in the MRF4-transfected fibres compared to MRF4-normal fibres 
and in the sham-transfected compared to sham-normal fibres (figure 3.3).  
This suggests possible individual differences in the cross-sectional area in MRF4 treated 
muscles and sham treated muscle possible due to differences in stretch and the area were the 
muscles were sectioned. The cross-sectional area in MRF4- and sham-transfected fibres was 
therefore also analysed as percentage of the normal fibres;   
 There is no significant difference in the cross-sectional area between the MRF4- and 
sham-transfected 2x and 2b fibres  
 There is a significant higher cross-sectional area in 2a fibres in the sham-transfected fibres 
compared to the MRF4-tansfected fibres but this group has very few observations (figure 3.4).  
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Figure 3.3 Cross-sectional area of each fibretype in normal fibres. 
2a fibres have the lowest cross-sectional area, 2b fibres have the highest cross-sectional area and 2x fibres have 
intermediate cross-sectional area, this coincide with the general conception of the cross-sectional area in the different 
fibre types. The difference in the cross-sectional area between the fibre types is significant between 2a and 2x fibres, 
and 2a and 2b fibres (*), and between 2x and 2b fibres (§) in all experiment groups. The average area of the 2a, 2x 
and 2b fibre types show a significant difference in the cross-sectional area between the MRF4- and sham-transfected 
fibres and between the MRF4-normal fibres and sham-normal fibres, but not between the MRF4-transfected fibres 
and MRF4-normal fibres, and between sham-transfected and sham-normal fibres. 
 
 
 
Cross-sectional area: 2b
M RF4 Sham
0
50
100
150
200
Cross-sectional area: 2x
M RF4 Sham
0
50
100
150
200
Cross-sectional area: 2a
MRF4 Sham 
0
50
100
150
200
 
 
Figure 3.4 Cross-sectional areas in MRF4 and Sham transfected fibres. 
The cross-sectional area as percentage of the average means of the normal fibres, show no significant difference 
between MRF4 -and sham-transfected 2b and 2x fibres. * There is a significant higher cross-sectional area in the 
sham-transfected 2a fibres compared to the MRF4-transfected 2a fibres, but there are very few observations in this 
group.  
* 
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3.4. SDH activity 
 Normal SDH activity between fibre types show highest activity in the oxidative-
glycolytic 2a fibres, lowest activity in the glycolytic 2b fibres and intermediate SDH activity in 
the 2x fibres. All experiment groups showed normal distribution of SDH activity between the 
fibre types (figure 3.5). 
 The average SDH activity in all muscles taken together, show a significant higher SDH 
activity in sham-transfected 2a fibres compared to MRF4 transfected 2a fibres and MRF4-normal 
2a fibres, but not to sham-normal 2a fibres. There is no significant difference in SDH activity 
between MRF4-transfected 2a fibres and MRF4 normal fibres. There is a significant higher SDH 
activity in sham-transfected 2x fibres and sham-normal 2x fibres compared to MRF4-transfected 
2x fibres. There is no significant difference in MRF4-transfected 2x fibres compared to MRF4-
normal fibres, and MRF-normal 2x fibres compared sham-normal 2x fibres. There is no 
significant difference in SDH activity in 2b fibres between any of the experiment groups (figure 
3.5). 
 These differences observed in SDH activity in 2a and 2x fibres, might due to either 
observations in some of the experiment groups or differences in the strength of SDH staining 
between the individual sections. To correct for these possible differences, the SDH activity was 
also analysed as percentage of the normal fibres. 
 There was no significant difference in the SDH activity between the MRF4 -and sham 
transfected 2a, 2x and 2b fibres (figure 3.6)  
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Figure 3.5 SDH activity in each fibre type. 
There is a normal distribution of SDH activity between the fibre types in all experiment groups. 2a fibres have the 
highest SDH activity, 2b fibres have the lowest SDH activity and 2x fibres have intermediate activity. The oxidative 
capacity is significant higher in 2a fibres compared to 2x and 2b fibres (*), and in 2x fibres compared to 2b fibres (§) 
in all experiment groups. The average SDH activity in 2a fibres show a significant higher SDH activity in sham-
transfected fibres compared to MRF4 transfected fibres and MRF4-normal fibres, but not compared to sham-normal 
fibres. There is no significant difference in MRF4-transfected 2a fibres and MRF4 normal 2a fibres. In 2x fibres 
there is significant higher SDH activity in sham-transfected fibres and sham-normal fibres compared to MRF4-
transfected fibres. There is no significant difference in MRF4-transfected fibres compared to MRF4-normal fibres, 
and MRF-normal fibres and sham-normal fibres. There is no significant difference in the SDH activity in 2b fibres 
between the four experiment groups.  
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Figure 3.6 SDH activity in MRF4 -and Sham-transfected fibres. 
The SDH activity as percentage of the average SDH activity in the normal fibres, show no significant difference in 
the SDH activity between MRF4 -and sham transfected 2a, 2x and 2b fibres. 
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4. Discussion 
 Overexpression of MRF4 did not lead to any change in the cross-sectional area and SDH 
activity compared to normal and sham-transfected fibres. The fibre type distribution showed a 
significant higher number of 2b fibres in both MRF4 -and sham-transfected fibres compared to 
normal, non-transfected fibres, and subsequent fewer 2a and 2x fibres in both MRF4 -and sham-
transfected fibres, compared to non-transfected fibres. Because of a possible selective 
transfection of the largest fibres, it is problematic to determine whether there has been an effect 
of the MRF4 treatment on the MyHC phenotype. 
   
4.1. Does MRF4 have an effect on MyHC expression? 
 When fast or slow muscles are subjected to a slow or fast electrical activity pattern, 
respectively, the activity pattern can induce a shift in the MyHC isoforms in a slow or fast 
direction (Lomo et al., 1974; Eken & Gundersen, 1988; Ausoni et al., 1990; Windisch et al., 
1998). This change in MyHC isoforms due to the electrical activity indicate that there are 
signalling pathways that link electrical activity to elements that regulate the expression of 
contractile proteins. In order to map these signalling pathways, several DNA regulatory 
sequences that might regulate the expression of contractile proteins has been studied, and 
regulatory elements that contain E- boxes and Mef-2 sites seems to be important in regulating the 
expression of contractile proteins. These regulatory sequences can bind to the myogenic bHLH 
factors, which suggest that at least some of these myogenic factors could be a link in the pathway 
between electrical activity and gene expression.  
 Hughes et al, (1997)  saw that in mice absent of MyoD, there was a shift from a fast 
muscle fibre type toward a slower fibre type in fast muscles and a shift toward a faster phenotype 
in slow muscle. This suggests that MyoD has a role in maintaining the fast fibre type in adult 
muscle, and it’s a further indication of that bHLH transcription factors might regulate the 
expression of MyHC isoforms in adult muscles. 
  Overexpression of MRF4 in the fast EDL muscle showed a significant higher number of 
2b fibres in both MRF4 -and sham transfected fibres compared to non-transfected fibres. In 
addition there were also a significant higher number of 2b fibres in the sham-transfected fibres 
compared to MRF4-transfected fibres. If we just compare the MRF4-transfected fibres with the 
sham-transfected fibres, the smaller number of 2b fibres in the MRF-transfected fibres, might be 
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caused by a transformation in MyHC in the slow direction due to the treatment with MRF4, but if 
we compare the MRF-transfected fibres with the normal, non-transfected fibres there is no 
change in the slow direction, but rather in the fast direction. I propose that the higher amount of 
2b fibres in MRF4-transfected fibres and sham-transfected fibres compared to non-transfected 
fibres is not a transformation of MyHC isoforms but I rather speculate that it is a result of a 
selective transfection as an effect of electroporation properties, effect of the lacZ reporter gene or 
both.  
 The transfection procedure might be more efficient in larger fibres apposed to smaller 
fibres as the conveyance of electrical current through the fibre might be facilitated in fibres with a 
larger cross-sectional area. There are technical aspects, like how you hold the electrodes, the 
distance between the electrodes, how much fluid that surrounds the muscle and how much 
voltage that is used, which all can influence the conveyance and effect of the current on the 
muscle. In this experiment, a combination of all these technical aspects and to low voltage might 
have an influence on the current so that it is only strong enough to induce a transfection in the 
largest fibres.  Several studies have used this technique to study gene transfer in vivo (Ekmark et 
al., 2003, unpublished studies in our lab) where such properties of the electroporation has not 
been reported, it has however been reported in one similar study (Grönevik, master thesis, 2000), 
where a higher number of 2b fibres were observed in transfected fibres compared to normal 
fibres. 
In addition to the possible selective transfection as an effect of the electroporation 
properties, there might be an effect of the lacZ itself. Vitadello et al. (1994) reported infiltrates of 
mononuclear cells surrounding about 50% of the fibre expressing lacZ. This indicates an immune 
reaction round the lacZ transfected cells and it can no be excluded that such an immune reaction 
might possible induce hypertrophy of fibres. 
  If one assumes a selective transfection of the largest fibres, then the difference in 
number of 2b fibres between the MRF4- and sham-transfected fibres, might be explained by a 
difference in fibre size in the individual muscles. The average area in sham-transfected fibres and 
sham-normal fibres are significant higher than in MRF4-transfected fibres and MRF4-normal 
fibres. This indicates that there is an individual difference in fibre size between the muscles 
probably due to difference in stretch and the position where the muscles were sectioned.  
 
Chapter 4                                                                                                                           Discussion 
                                                                                                                                                     30 
4.2. Has MRF4 an effect on the cross-sectional area?  
 The cross-sectional area is known to be smaller in type I fibres, increasing in 2a and 2x 
fibres, and be at its largest in 2b fibres. This arrangement is advantageous because slow enduring 
muscles need short diffusion distances to accommodate the high supply of oxygen and nutrition 
to the exterior. 
 Endurance training has been shown to induce a reduction in the cross-sectional area 
(Brown et al., 1976; Tamaki, 1987), and overexpression of myogenin in the fast EDL muscle has 
also shown a reduction in the cross-sectional area of type II fibres, without a prior change in 
MyHC isoforms (Ekmark et al., 2003) 
 Overexpression of MRF4 showed no change in the cross-sectional area in the MRF4-
transfected fibres compared to the control group. Because of individual differences in the average 
area between the muscle pairs in each animal, the cross-sectional area was analysed as the 
percentage of the average cross-sectional area in the normal fibres. The average cross-sectional 
area in each fibre type in all experiment groups, show a normal arrangement of the cross-
sectional area, where the 2a fibres have the smallest cross-sectional area and the 2b fibres have 
the largest cross-sectional area. 
 This suggests that MRF4 does not contribute in regulation of muscle fibre size in adult 
animals. 
 
4.3. Has MRF4 an effect on the oxidative metabolism? 
 Increase in oxidative metabolism has been seen in many studies as a response to 
endurance training (Baldwin et al., 1972; Holloszy & Booth, 1976). Ekmark et al, (2003) showed 
that overexpression of myogenin in the fast EDL muscle also induces an increased oxidative 
metabolism similar to the one that is seen during exercise. This change has been seen without a 
change in MyHC isoforms. 
 Overexpression of MRF4 showed no change in the SDH activity in MRF4-transfected 
fibres compared to any of the control groups. Amongst the type 2 fibre type population in normal 
fibres, the 2a fibres has the highest oxidative metabolism, while the 2b fibres are glycolytic and 
has the lowest oxidative metabolism. The average SDH activity in the different fibre types in this 
study also shows this normal pattern, and suggests that MRF4 does not have an effect on the 
oxidative metabolism in adult muscle fibres. 
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4.4. Does MRF4 have no role in regulating fibre type specific patterns of gene 
expression? 
 Zhang et al, (1995) also explored the idea of MRF4 being involved in fibre type 
specificity in adult muscles. They generated MRF4-null mice and looked at the expression of a 
subset of muscle specific genes. They saw no difference in transcripts of the contractile proteins; 
muscle creatine kinase (MCK), slow troponin I (TnI), a-skeletal actin and the β-subunit of the 
acetylcholine reseptor (AChR) in adult MRF4-null transgenes, compared to normal adult skeletal 
muscle. MyHCIIa, MyHCIIb and MyHCIIx were also expressed at normal levels in MRF4-null 
adults. The distribution of fast- and slow twitch fibres in adult MRF4-null hind limb muscle were 
also normal, and this lead to the conclusions that MRF4 is not required for expression of muscle 
specific genes at adult stages, and that MRF4 is not required to establish normal distribution of 
adult fast- and slow-twitch fibres. They also saw an up-regulation of myogenin in the MRF4 
knock outs, which suggests that myogenin might compensate for the lack of MRF4 and that this 
compensation might have led to a normal expression of contractile proteins and a normal fibre 
type distribution in adult MRF4 knock outs. Compensatory mechanisms have been seen in 
several knock out studies in transgenes where, during the development, one or more factors seem 
to be able to compensate for the loss of another. My study was conducted on normal adult muscle 
to exclude or at least minimize such a compensatory mechanism (one can not exclude the 
existence of compensatory mechanisms in adult muscle as well). My findings in this study 
thereby further support the notion that MRF4 does not contribute to fibre type specificity in adult 
muscle. 
  Hughes et al. (1993) found that there is a selective accumulation of MyoD and myogenin 
mRNA in fast and slow adult skeletal muscle respectively, which suggests that the myogenic 
HLH transcription factors restrict expression of muscle genes to specific fibre types. They further 
suggest that individual genes may respond differently to distinct members of the myogenic HLH 
family, and this might explain how levels of MyoD and myogenin protein might control fibre 
type specific gene expression even though MRF4 mRNA is accumulated to much higher levels 
than either MyoD or myogenin mRNA in adult muscle fibres, and that it is possible that the 
myogenic HLH proteins discriminate between muscle-specific enhancers in vivo, perhaps through 
interaction with distinct coregulators. 
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 This study and the study by Zhang et al contradicts the study by Voytik et al.(1993), 
which suggest that MRF4 plays a crucial role in preserving adult muscle fibre type based on the 
high levels of MRF4 mRNA that is expressed in adult muscle. Moreover, Weis et al. (2000) 
showed that despite the high level of MRF4 mRNA expression in adult muscle, they found no 
observations of MRF4 protein expression in normal innervated adult muscles using an antiserum 
specific to MRF4. They could however not exclude the possibility that MRF4 protein in 
innervated muscle is either expressed in so low levels or distributed throughout the cytoplasm to 
make it undetectable immunohistochemically, but this study might indicate that the protein 
expression does not coincide with the mRNA expression. 
 Walters et al, (2000) saw that MRF4 mRNA seems to be preferentially expressed in slow 
fibre types than in the fast fibre type population in the mixed gastrocnemius muscle and therefore 
suggest that MRF4 might exhibit a high degree of fibre type specificity at the mRNA level. They 
saw however no difference in expression between subpopulations of fibres in the slow soleus 
muscle and the mean levels of expression of MRF4 transcripts in type I fibres in the soleus were 
lower than in the type I fibres in the gastrocnemius muscle. This difference in MRF4 mRNA 
levels between the type I fibres in the two different muscles is suggested to due to different 
development pathways or neural activity patterns in the different muscle types.  
 Looking at all these studies and my study taken together, I think, that the role of MRF4 in 
preserving fibre phenotypes in adult muscle is certainly questioned and that the evidence leans 
towards suggesting that MRF4 does not have a role in regulating fibre type specific patterns of 
muscle gene expression in adult skeletal muscle.  
 
4.5. Other possible functions of MRF4? 
Supposed that MRF4 does not have a function in regulating fibre type specificity in adult skeletal 
muscle, what might the role of MRF4 be in adult muscles? 
 Looking further at the study by Weis et al. (2000), they, in addition to finding no MRF4 
protein expression in innervated normal muscles, also investigated the MRF4 protein expression 
in denervated adult muscles. Here, they saw a quickly increase in nuclear MRF4 
immunoreactivity after denervation. No immunostaining was detected beyond 14 days after 
denervation.  There was no apparent difference in the expression of MRF4 protein between type I 
and type II fibres after the denervation which is consistent with the equal distribution of MRF4 
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mRNA transcripts in innervated and denervated slow-and fast-twitch muscle of rats. They also 
showed that MRF4 immunoreactivity was detected before MyoD and myogenin, and suggested 
that this faster appearance of protein might due to the already high levels of MRF4 mRNA. 
 Their study suggests that MRF4 has a role in the transcriptional regulation of muscle genes as a 
response to denervation. Denervation causes a situation in the muscle similar to what occurs 
when a muscle is regenerating after damage, and Zhou & Bornemann  (2001) showed that MRF4 
is translated in vivo after a muscle have been stimulated to regenerate. They saw no expression of 
MRF4 protein in adult myoblasts, which differ from the other myogenin bHLH factors, but it was 
detected early in myofibre nuclei. They suggest that the MRF4 protein is not involved in the early 
regenerative events of proliferation and regeneration of adult myoblasts, but around and after the 
time of fusion into myofibres. 
 These studies suggest that MRF4 might have a role in the regeneration program in adult 
muscles after muscle damage. 
 
4.6. Future perspectives 
Based on the study by Weis et al. (2000), it would be interesting to further investigate the role of 
MRF4 after denervation. I did some experiments in this study where I overexpressed MRF4 in 
the EDL and then denervated the muscle to see if MRF4 could prevent transformation in a fast to 
slow direction that normally occurs after denervation (Huey & Bodine, 1998), but there were not 
enough data to give an indication of this and this ought to be explored further.  
 It could also be interesting to overexpress MRF4 in the mixed gastocnemius muscle, since 
there is evidence that MRF4 is expressed predominantly in the slow fibres in this muscle 
(Walters et al., 2000). 
 The study by Zhou & Bornemann (2001)  suggest further studies on regenerating muscle 
in MRF4-null mutants to clarify the role of MRF4. 
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4.7. Conclusions 
• Overexpression of MRF4 in the fast EDL muscle gave no significant changes in the cross-
sectional area and the SDH activity in type 2x and 2b fibres in MRF4-transfected fibres 
compared to sham-transfected fibres 
• Overexpression of MRF4 in the fast EDL muscle gave a significant higher number of 2b 
fibres in both MRF4- and sham-transfected fibres compared to normal fibres and a 
subsequent decrease in the number of 2a and 2x fibres. I attribute this higher number of 
2b fibres to be caused by a selective transfection of the largest fibres as an effect of 
electroporation properties, and not an effect of the treatment with MRF4. 
 
These findings give no support to the hypothesis that MRF4 may have a role in regulating fibre 
type specific patterns of muscle gene expression in adult skeletal muscle. 
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5. Appendix A 
 
5.1. Equethesin (catalognumber 702821, Ullevål farmasy) 
 
Chloral hydrate 42,5 mg
Magnesium sulphate 21,0 mg
Pentobarbiton 9,7 mg
Ethanol (96%9 76,0 mg
Propylenglycol 428,0 mg
dH2O 50,0 ml
 
 
 
 
5.2. pAP- MRF4 DNA solution (100µl) 
 
pAP-MRF4 in H2O (2µg/µl) 25 µl
NaCl, 4M 4µl
dH2O 71 µl
 
 
 
 
5.3. pAP-MRF4 and pAP-lacZ DNA solution (100µl) 
 
pAP-MRF4 in H2O (2µg/µl) 25 µl
pAP-lacZ in H2O (2µg/µl) 25 µl
NaCl, 4M 4µl
dH2O 46 µl
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5.4. Staining for β-gal activity 
 
1. Wash the sections in PBS (pH=7,1) 
2. Make the fixation solution: 
Formaldehyde 2.0 g 
Glutaraldehyde 400μl 
10xPBS 10.0 ml 
dH2O 69.2 ml 
 
Solve the formalaldehyde in dH2O warmed to 600C. Adjust the volume to100 ml. 
Adjust the pH to 7.4. 
3. Fixate the sections at 40C 
4. Wash the sections in PBS. 
5. Make the staining solution: 
10xPBS 150μl 
Potassium Ferrocyanide 30μl 
Potassium Ferricyanide 30μl 
MgCl2 3μl 
dH2O 1260μl 
X-gal DMSO 30μl 
 
6. Stain over night at 370C. 
7. Wash the sections in PBS 
8. Mount the sections in glycerine gel. 
 
Gelatine 15.0 g 
Glycerol 100 ml 
dH2O 100 ml 
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5.5. Staining for SDH activity 
1.  Make the tetrazolium solution: 
 
MTT: 1mg/ml dH2O 2,5 ml 
Tris-buffer: 32,5 ml 0,1 M HCl in 42,5 dH2O (pH 7.4) 2,5 ml 
CoCl2, 0.5M 0,5 ml  
MgCl2, 0.05M 1,0 ml 
dH2O 2,5 ml 
 
2. Make the substrate solution: 
Sodium succinate 6,75 g 
dH2O 8,0 ml 
 
3. Make the staining solution: 
Tetrazolium solution 0,9 ml 
Substrate solution 0,1 ml 
 
4.  Make a hydrophobic ring round the sections with a hydrofobic-penn (H-4000, Vector). 
5.  Incubate the sections in the staining solution for 45 min at 370C. 
6.  Make fixation solution as in appendix 5.5. 
7.  Incubate the sections in the fixation solution for 20 min at 40C. 
8. Wash the sections 3X5 min in PBS (pH 7.4). 
9. Mount the sections in glycerine gel as in appendix 5.4. 
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5.6. Staining of MyHC 
Staining for MyHC I, MyHC IIa, and all MyHC II antibodies. 
1.  Make a hydrophobic ring round the sections with a hydrofobic-penn (H-4000, Vector). 
2.  Dilute the primary antibody 1:1000 in 1% BSA in PBS (pH 7.4). 
3.  Incubate the sections with the primary antibody for 1 hour in room temperature. 
4.  Wash the sections 3X5 min in PBS (pH 7.4). 
5. Dilute the secondary antibody 1.100 in 0,5% BSA in PBS. 
6.  Incubate the sections with the secondary antibody for 30 min at 370C. 
7.  Wash the sections 3X5 min in PBS (pH 7.4). 
 
 
MyHC Primary antibody Secondary antibody 
I Sc-71 Anti-Mouse Ig, Rhodamine (1214608, Boeheringer) 
IIa MY-32 Anti-Mouse Ig, Rhodamine (1214608, Boeheringer) 
All type II BA-D5 Anti-Mouse Ig, Rhodamine (1214608, Boeheringer) 
 
Staining for the MyHC IIb antibody 
1.  Make a hydrophobic ring round the sections with a hydrofobic-penn (H-4000, Vector). 
2. Pre-incubate the sections with 1% PBS for 60 min at 40C. 
2.  Dilute the primary antibody 1:2000 in 0,5% BSA in PBS (pH 7.4). 
3.  Incubate the sections with the primary antibody for 45 min. in room temperature. 
4.  Wash the sections 3X5 min. in PBS (pH 7.4). 
5. Dilute the secondary antibody 1.300 in 0,5% BSA in PBS. 
6.  Incubate the sections with the secondary antibody for 45 min. at 370C. 
7.  Wash the sections 3X5 min. in PBS (pH 7.4).  
 
MyHC Primary antibody Secondary antibody 
IIb BF-F3 Anti-mouse IgM, Cy-3 (J115-165-020, Jackson 
ImmunoResearch Laboratories) 
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6. Appendix B 
 
6.1. Abbreviations 
 
AchR: Acetylcholine reseptor 
ATP: Adenosin tri phosphate 
β-gal: β-galactosidase 
bHLH: Basic Helix Loop Helix 
CaMK: Ca2+/Calmodulin dependent protein kinase 
DNA: Deoxyribonuclei acid 
EDL: Extensor digitorum longus 
E8: Embryonic day eight 
FFA: free fatty acid 
MAPK:Mitogen activated protein kinase 
MCK: Muscle creatin kinase 
MDF: Myogenic determination factor 
Mef-2: Myosite enhancer factor 
MRF4: Myogenic regulation factor 4 
mRNA: Messenger Ribonuclei acid 
Myf-5: Myosin factor 5 
MyHC: Myosineheavy chain 
NFAT: Nuclear factor of activated t-cells 
NIH: National institutes of health 
PKC: Protein kinase C 
PPARδ: Peroxisome proliferators activated receptor delta 
PGC-1: Peroxisome proliferators activated receptor gamma coactivator 1 
Ras: Rat sarcoma 
RSV: Rouse sarcoma virus 
SDH: Succinat dehydrogenase 
SIT: silicon intensified tube 
TnI: Troponin I
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